Bolt Biotherapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "MACROMOLECULE-SUPPORTED AMINOBENZAZEPINE COMPOUNDS (FOR THE TREATMENT OF CANCER)".
Benzinga Newsdesk 11 months ago
BiotechNewsGeneral
https://x.com/PatentGrants/status/1998150771544928598?s=20